REGENXBIO (RGNX) News
NASDAQ: RGNXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
7.16-0.02 (-0.28%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
RGNX news summary
We found 7 recent headlines mentioning REGENXBIO (RGNX): 0 in the past week and 6 in the past 30 days, most often from PR Newswire, Nasdaq, Seeking Alpha. For price context, RGNX is down 0.28% at $7.16. The most recent story, "Regenxbio outlines RGX-202 full BLA filing in Q1 2027 with cash runway late into Q4 2027", was published by Seeking Alpha on Nov 5, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest REGENXBIO headlines
- Regenxbio outlines RGX-202 full BLA filing in Q1 2027 with cash runway late into Q4 2027Seeking Alpha
- Regenxbio Inc Q3 Loss Drops(RTTNews) - Regenxbio Inc (RGNX) released Loss for third quarter of -$40.738 millionNasdaq
- REGENXBIO Reports Third Quarter 2026 Financial Results and Operational HighlightsRGX-202 BLA submission for Duchenne muscular dystrophy on track for Q1 2027, with potential accelerated approval in 2H 2027 Topline data from pivotal subretinal wet AMD studies, ATMOSPHERE® and…PR Newswire
- 4 Biotech Stocks Likely to Outpace Q3 Earnings EstimatesFour biotech stocks, including TG Therapeutics and Immunome, show positive Earnings ESPs and favorable Zacks Ranks, positioning them for potential third-quarter earnings beats.NasdaqTGTX, RGNX, IMNM, PMN
- REGENXBIO to Participate in Stifel 2026 Healthcare ConferenceROCKVILLE, Md., Nov. 3, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the Stifel 2026 Healthcare Conference. Fireside Chat Details Date and Time:…PR Newswire
- REGENXBIO to Host Conference Call on November 5 to Discuss Third Quarter 2026 Financial Results and Operational HighlightsROCKVILLE, Md., Oct. 29, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Thursday, November 5, at 8:00 a.m. ET to discuss its financial…PR Newswire
- REGENXBIO to Host Investor Event Highlighting Surabgene Lomparvovec (Sura-vec) in Wet AMD on October 20Event to include clinical program overview and perspectives from leading retina specialists ahead of topline pivotal data readout anticipated in 4Q 2026 ROCKVILLE, Md., Oct. 12, 2026 /PRNewswire/ --…PR Newswire